ABSTRACT. In previous research, we showed that when peripheral blood mononuclear cells (PBMC) from patients with idiopathic minimal lesion nephrotic syndrome (IMLNS) in relapse were cocultured with rat glomeruli, there was an increased glomerular basement membrane (CBM) uptake of 35sulPate. This study was done to determine whether the increased uptake was due to substances secreted into the nephrotic P B M C culture supernatants. "sulfate uptake in rat G B M was significantly higher when glomeruli were cocultured with P B M C from 12 I M L N S patients in relapse (geometric mean [GM] = 513 cpmlmg) than when simultaneous assays were done using either PBMC from eight control subjects ( G M = 158) (p < 0.05) or glomeruli incubated without P B M C ( G M = 275 cpm/ mg) (p < 0.01). 35sulfate uptake did not increase when glomeruli were cocultured with PBMCs from I1 M L N S ~a t i e n t s in remission. Rat G B M 35su1fate uptake was significantly higher when glomeruli were incubated in the supernatants of the PB%lC cultures from 16 I M L N S patients in relapse ( G M = 234 cpm/mg) than it was when glomeruli were cultured in the supernatants from normal control P B M C ( G M = 126 cpm/mg; p e 0.002) or from glomeruli cultured alone ( G M = 141 cpm/mg) (p < 0.04).
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Supernatants from P B M C cultures of 11 I M L N S patients in remission did not increase rat G B M 35sulfate uptake. These data suggest that PBMC from IM1,NS patients in relapse secrete a factor(s) released into supernatants that increases the "sulfate rat G B M uptake. Since sulfated compounds in the G B M play a role in glomerular permeability, this finding may have pathogenic significance. (Pediatr Hes (19: 836-840, 1985) Abbreviations IMLNS, idiopathic minimal lesion nephrotic syndrome GBM, glomerular basement membrane PBMC, peripheral blood mononuclear cells GM, geometric mean cpm, counts per minute
Proteinuria in IMLNS appears to be a consequence of defective electrostatic function of the glomerular barrier to protein filtra-tion (1). Heparan sulfate, the predominant proteoglycan in the GBM (2)-is present as regularly spaced negatively charged sites along the lamina raraes of the GBM (3). This proteoglycan seems to participate in the glomerular ultrafiltration banier, since its removal from the GBM is associated with an increase in glomerular permeability (4) . Sulfate groups in heparan sulfate are an important source of anionic sites. The study of GBM sulfate metabolism may give clues to the increased glomerular permeability observed in patients with TMLVS.
Previously we reported that cocultures of PBMC from IMLNS patients in relapse and rat glomeruli showed an increased incorporation of 35sulfate in the GBM of the rat glomeruli (5) . This study confirmed our previous findings and demonstrated that the increased 35sulfate incorporation is due to a factor secreted in the supernatants by the PBMC.
MATERIALS AND METHODS
Patients. Eighteen patients with IMLNS as defined by the International Study of Kidney Disease in Children (6) were included in the study. Fourteen were males and four were females. Their ages ranged from 25/12 to 21 yr with a median age of 9 yr. Eight normal adults served as controls.
Sixteen of the 18 IMLNS patients were studied during relapse. Nine of these patients were also studied during remission. The remaining two patients were studied during remission only. Patients were considered in relapse if they had massive proteinuria (3+ by Albustix or >40 mg/m2/h) and low serum albumin ( 4 . 5 g/dl). Patients were considered in remission when serum albumin was within normal limits and protein excretion was normal (trace or negative by Albustix or <5 mg/m2/h).
No ~a t i e n t was receiving ~rednisone at the time of the study. Isohtion of PBMC. ~ehpheral blood mononuclear cells were isolated from heparinized blood by density centrifugation on a Ficoll Hypaque gradient (7) . After the cells had been washed three times with Hanks' balanced salt solution, viability was assessed by trypan blue exclusion (>95% in all preparations).
Isolution of rat glomeruli. Glomeruli from Sprague-Dawley rats (100 to 350 g; Charles River, Wilmington, MA) were isolated by the method described by Fong and Drummond (8) . At the end of the procedure, preparations were almost pure of tubular contaminations and consisting of virtually 100% glomeruli. The glomeruli obtained from each rat were divided into three aliquots. One was cocultured with PBMC from nephrotic patients, another was cocultured with PBMC from normal control subjects at the same concentration as nephrotic PBMC, and the third was cultured alone. PBMC from seven of the patients in relapse and those from seven control subjects were divided into two equal aliquots. One was cocultured with rat glomeruli as described above and the other was cultured alone but with 35sulfate added to the culture media.
Glomeruli and PBMC were incubated in 5 ml of Basal Eagle Medium (without sulfate, Catalog no. 424-1300, Grand Island Biological Company, New York, NY). The culture medium was supplemented with 200 mM glutamine, 100 IU/ml penicillin, 100 pg/ml streptomycin, 20% decomplementcd fetal calf serum, and 80 pCi of 35sulfate (specific activity, 209-335 mCi/mM; New England Nuclear, Boston, MA). Glomeruli and PBMC. glomeruli alone, and PBMC alone were incubated at 36" C with Petri dishes (50 x 50 mm) in a humidified atmosphere of 5% C02
and 10% Oz for 48 h. At the end of incubation, the samples were centrifuged, the supernatants were collected, and the pellet was lyophilized and kept at -35" C until the GBM was isolated.
In the next experiment, glomeruli from rats were again divided into three aliquots. One was cultured in the supernatant from nephrotic PBMC and glomeruli cultures, another in the supernatant from normal PBMC and glomeruli cultures, and the third in the supernatant of rat glomeruli cultured alone. In a concomitant experiment rat glomeruli were cultured with supernatants from PBMC of patients in relapse and those of normal control subjects.
Isolatior~ of GBiM. GBM was prepared from lyophilized, isolated glomeruli by the method Meezan et al. (9) with minor modifications. Lyophilized samples were weighted and glomeruli were hypotonically lysed in 100 ml of 0.05% sodium azide for 12 h. Subsequently, lysed samples were treated with desoxyribonuclease (50 Kunitz units/ml) for 2 h and then digested with 4% sodium desoxycholate for 2 h. The final mixture was centrifuged, the supernatant discarded, and the pellet washed five times with distilled water by resuspension and centrifugation. The washed precipitate was dried and resuspended in Atomlight (New England Nuclear); radioactivity was counted for 1 min in a Beckman liquid scintillation counter. Results were expressed in cpm/mg dry glomerular weight. To compare 35sulfate incorporation in rat GBM when glomeruli were incubated with PBMC from same patient during relapse and remission, results were expressed in cpm/mg dry glomerular weight per lo6 PBMC. Serum albumin was determined by the brown-creosol-grecn method using a Technicon Autoanalyzer 11. Urinary protein was measured by the sulfosalicylic method.
Statistical analysis was performed on an IBM PC cornputter using NWA Statpak (Northwest Analytical Inc, Portland, OR). Programs included one-way analysis of variance, randomizecd, block assignment, and multiple I tests. Analysis of variance artd differences between means were performed on the logarithms of the measured values of 35sulfate uptake by the GBM.
RESULTS
During relapse the serum albumin concentration of patients with IMLNS was 2.3 + 0.3 g/dl (mean + SD), while during remission it was 4.2 + 0.5 g/dl. The serum creatinine concentration was 0.6 + 0. l mg/dl during relapse and 0.5 k 0.1 during remission ( p = NS). 35Sulfate incorporation in rat GBM was significantly higher when glomeruli were cocultured with PBMC fro111 IMLNS patients in relapse (GM = 5 13 cpm/mg) than in the cultures fr0.m normal control subjects (GM = 158 cpm/n~g; p < 0.05) and in cultures of glomeruli without PBMC (GM = 275 cpm/mg; p < 0.0 1) ( Table 1) . Although 16 patients were studied during relapse, data on 35S04 uplake by GBM when glomeruli were cocultured with nephrotic PBMC were available in only 12 patients.
The 35sulfate incorporation after glomeruli were cultured with PBMC from 1 1 IMLNS patients in remission did not difier significantly from that observed when glomeruli were incubated with PBMC from normal adults or when glomeruli were incubated alone. (ANOVA F = 2.36; degree of freedom 2,20; (1 = NS) ( Table 2.)  Tables 3 and 4 show 35sulfate incorporation in rat GBM aftjer glomeruli were incubated in the supernatants of the previously described types of cultures. GBM 3Ssulfate incorporation w,as significantly higher when glomeruli were incubated in the supernatants of PBMC from 16 IMLNS patients in relapse (GM = 234 cpm/mg) than it was when glomeruli were cultured in the poration when glomeruli were cultured in the supernatants from supernatants from normal control PBMC (GM = 126 cpm/mg; normal PBMC or from glomeruli cultured without PBMC. (ANp < 0.002) or from glomeruli cultured without PBMC (GM = OVA: F: 2.36, degree of freedom 2,20; p = NS) ( Table 4 .) 14 1 cpm/mg; p < 0.04) ( Table 3.) 35Sulfate incorporation was significantly higher ( p < 0.01) No significant differences in "sulfate GBM uptake were found when glomeruli were incubated in supernatants from PBMC of when glomeruli were cultured in the supernatants from 1 1 PBMC seven patients in relapse as compared to the incorporation obof IMI.NS patients in remission as compared to "sulfate incor-served when glomeruli were incubated in supernatants from the Significance of difference same PBMC that had been previously cultured with glomeruli (Table 5) . No significant differences in 35sulfate uptake were seen between same types of supernatants but from control subjects' PBMC. When glomeruli were incubated with PBMC from nine patients in relapse the 35sulfate uptake increased significantly (GM = 479 cpm/mg dry glomerular weight per lo6 PBMC) compared with that seen when glomeruli were incubated with PBMC from the same patients in remission. (GM = 83 cpm/mg per 10" PBMC) (17 < 0.01) ( Table 6 .) DISCUSSION In this study we confirmed our initial finding of increased incorporation of 35sulfate in rat GBM when glomeruli were incubated with PBMC from patients kvith IMLNS in relapse ( 5 ) .
As in our previous report, control PBMC were obtained frorn normal adult subjects rather than from age-, sex-matched children or adolescents. However, no significant differences in 35sulfate have been found between PBMC cultures taken frorn patients in relapse from glomerulopathies other than IMLNS and those from normal subjects (5). This highly suggests that the PBMC-induced increased "sulfate incorporation is not age dependent. Our data as well as those of others (10) evaluating the metabolism of sulfated compounds in rat GBM in vitro have shown great variability. In our study, variability could have been exaggerated by the use of rats of different ages, since metabolisrn of proteoglycans is known to change with age (1 1). Moreover, rat glomeruli were incubated with different concentrations of PRMC. However, although the data are variable, the variatior~s affected equally both experimental and control groups and thus can not explain our findings.
Our data show that the increased 35sulfate uptake is due to a factor(s) present in the supernatant of the cultured PBMC. This factor is likely derived from the PBMC and not from glomeruli that had been incubated with PBMC because the effect was observed even when supernatants were obtained from PBMC cultured alone. Since density centrifugation on a Ficoll Hypaque gradient isolatcs lymphocytes and monocytes, either or both of these cells may release the factor in the supernatant.
When glo~neruli were cultured with supernatant from glomeruli and PBMC cultures: 35sulfate incorporation was less than that observed when glomeruli were cultured with PBMC. This could be due to an additional direct effect of the PBMC on glomerular metabolism. However, a more likely explanation is a decrease in the factor concentration in the supernatant, since some of it was probably adsorbed by the glomeruli in the initial culture. This is supported by the finding of an increased 35sulfate uptake when glomeruli were cultured in supernatants from PBMC cultured alone as connpared to supernatants from glomeruli and PBMC cultures.
Previously we reported that the finding of increased 35sulfate incorporation seems to be specific for patients with IMLNS (5). Furthermore, it is not due to a heterologous reaction between human PBMC and rat glomeruli. When PBMC from normal control adults or PBMC from IMLNS patients in remission were cocultured with rat glomeruli, 35sulfate uptake did not differ frorn that seen when glomeruli were cultured without PBMC. Moreover. it is recognized that lipoproteins (1 2) and prostaglandin E 2 (1 3), known to be present in increased concentrations in th.e serum of these patients (14, 1 S), can modulate nephrotic PRMC functions. However, this is an unlikely explanation for our finding since the PBMC were not cultured with nephrotic serum. An effect of lipoproteins and/or prostaglandins E2 left on receptor cells after the PBMC washings is also unlikely because we did not observe an increase in 35sulfate when PBMC from patien-ts with active nephrotic syndrome and other type of glomerulopathies were cocultured with rat glomeruli (5) . Finally, because th.e abnormal sulfate GBM metabolism was found during relapse and not during remission, this finding may have pathogenic significance.
It is currently postulated that IMLNS could result from a disorder of T lymphocyte function (16) . Initial studies showing that lymphocytes from IMLNS patients produce a lymphokine (vascular permeability factor) that could increase glomerular permeability have been promising (17) . However, this finding has not been confirmed (1 8) or has been found to be nonspecific and present in other types of nephrotic syndromes (19) In this study, supernatants frorn cultures of PBMC frorn IMLNS in relapse did induce a change in the sulfate metabolisrn of rat GBM. Because the changes do not appear due to species differences, we suggest that the supernatant factor could also alter the sulfate rnetabolisrn of human GBM.
An increase in sulfate incorporation is likely associated with an increased synthesis of proteoglycan side-chains or glycoproteins in the GBM. We did not isolate the different 35sulfate-labeled compounds of the rat GBM. However, studies by Brown e! ul. (20) and Lemkin and Farquhar (2) have demonstrated that the "sulfate in rat GBM is incorporated into glycosaminoglycans and glycopeptides. The majority of the "sulfate is found in heparan sulfate. The glycopeptides have not been defined, but they may represent entactin, a recently described sulfated glycoprotein associated with basement membranes (2 l). The nephrotic PBMC may release a factor that induces increased catabolism of the GBM sulfated compounds, with subsequently increased synthesis as cells react to the increased catabolism. Conversely, the supernatant factor could directly stimulate the synthesis of proteoglycans and/or glycoproteins. Thus, the PBMC could be compensating for an already increased catabolism of sulfated cornpounds in the GBM. Because the sulfated compounds play a role in glomerular permeability, the answers to these questions will give us insight into the biological significance of this supernatant factor and possibly the pathogenesis of IMLNS.
